Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FF
- Chemical substanceL01FF13Toripalimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
At a glance
- ATC code
- L01FF13
- Registers
- 8
- Registrations
- 8
- With their own page
- 8
- Companies
- 5
All medicines with Toripalimab
Human medicines from every register that match Toripalimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Loqtorzi | United States | 240MG/6ML | injectable | Marketed | Coherus Biosciences INC |
| Loqtorzi | European Union | Authorised | Topalliance Biosciences Europe Limited | ||
| Loqtorzi 240 MG Concentrado Para Solucion Para Perfusion | Spain | 240 mg | concentrado para solución para perfusión | Marketed | Topalliance Biosciences Europe Limited |
| LOQTORZI 240 mg concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Topalliance Biosciences Europe Limited | |
| Loqtorzi | Canada | 40 MG / ML | Solution | Marketed | Apotex INC |
| Zytorvi | Brazil | Authorised | DR. Reddys Farmacêutica do Brasil Ltda | ||
| Loqtorzi Concentrate for Solution for Infusion 240MG/6ML | Singapore | 240mg/6mL | infusion, solution concentrate | Authorised | Ta Biosciences Pte. LTD. |
| Loqtorzi | Croatia | Authorised |